Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (NASDAQ: $CRON) (TSX: $CRON.TO), (TSXV: $NINE.V), (CSE: $LOVE.C), (OTCQX: $ITHUF) (CSE: $IAN.C), (CSE: $CROP.C) (OTC: $CRXPF), (TSX-V: $WL.V)
Delta, Kelowna, BC - January 24, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (NASDAQ: $CRON) (TSX: $CRON.TO), (TSXV: $NINE.V), (CSE: $LOVE.C), (OTCQX: $ITHUF) (CSE: $IAN.C), (CSE: $CROP.C) (OTC: $CRXPF), (TSX-V: $WL.V)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we are looking at announcements from Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), DELTA 9 CANNABIS INC. (TSXV: NINE), Cannara Biotech Inc. (CSE: LOVE), iAnthus Capital Holdings, Inc. (OTCQX: ITHUF) (CSE: IAN), Crop Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) and Westleaf Inc. (TSX-V: WL).
Cronos Group Inc. today announced that it has entered into a credit agreement with Canadian Imperial Bank of Commerce ("CIBC"), as administrative agent and lender, and the Bank of Montreal, as lender in respect of a $65 million secured non-revolving term loan credit facility. The Company intends to use the funds available under the Credit Facility to repay the Company's existing loan facility with Romspen Investment Corporation and for general corporate purposes pending the closing of the Company's previously announced equity investment by Altria Group, Inc.. The Company intends to repay the Credit Facility with a portion of the proceeds from the Investment.
The Credit Facility will mature on July 23, 2019, unless extended to September 7, 2019 with the consent of the Lenders.
DELTA 9 CANNABIS INC. announced that it has signed a Master License Agreement with NanoSphere Health Sciences, LLC and its Canadian subsidiary, NanoSphere Cannabis International Inc.
The Agreement provides Delta 9 with an exclusive license in Canada to manufacture and sell products made with Nanosphere's patented technology for the delivery of cannabinoids via nanoparticle technology (the "NanoSphere Delivery System of Cannabis"). The two companies are already working on the first product for Canada; an intraoral cannabis oil containing cannabinoid nanoparticles, that is being produced over the next month for an upcoming inspection for final approval by Health Canada.
"The Agreement paves the way for an entirely new form of consumption for both medical and recreational consumers of cannabis," said Delta 9, CEO John Arbuthnot.
"On the recreational side, we can now provide a healthier alternative to smoking or vaping cannabis, but that still gives you the same or better effect," said Arbuthnot. "Equally important, our NanoSphere products provide for the first time a truly appropriate way to deliver medical cannabis, with precise dosage, better bio-availability, and without essentially having to 'smoke your medicine'."
The NanoSphere Delivery System of Cannabis works by nano-encapsulating active ingredients in phospholipid membranes for transportation through the skin and mucosa into the bloodstream within minutes. Cannabis applications of the technology include transdermal viscous gels, intranasal products and intraoral products, all of which provide rapid results, precise dosages and high bioavailability. The NanoSphere Delivery System of Cannabis can eliminate the need for inhalation or ingestion of cannabis, offering users a potentially safer and more effective method of consumption.
Cannara Biotech Inc., a vertically integrated Cannabis company focused on cannabis-infused products, today announced it is entering the U.S. Hemp-CBD market, through a subsidiary, with an online e-commerce platform called shopCBD.com.
The new e-commerce platform will showcase retail products from Hemp-CBD manufacturers for the U.S. consumer market. With several vendors already committed, shopCBD.com intends to offer a variety of products, including tinctures, oils, capsules, body care, vape cartridges and pet-related products. shopCBD will provide a user-friendly online experience where consumers can purchase, review and compare a variety of CBD products.
"We are taking a leadership role by creating a hub for vendors to showcase their products and consumers to purchase Hemp-CBD products in a fast and easy way. We want to become the Amazon of CBD", said Zohar Krivorot, President and CEO of Cannara Biotech, a 15-year veteran in the tech and online industries.
With the recent passing of the 2018 Farm Bill in the U.S., CBD represents an emerging sector with many vendors seeking national reach to U.S. customers. The Company's strategy is to offer a wide variety of products from leading CBD brands, with competitive pricing and delivery times across the U.S.
iAnthus Capital Holdings, Inc., which owns, operates, and partners with licensed cannabis operations throughout the United States, announced it has been named to the 2019 OTCQX® Best 50, a ranking of top performing companies traded on the OTCQX Best Market last year.
The OTCQX Best 50 is an annual ranking of the top 50 U.S. and international companies traded on the OTCQX market. The list is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies on the 2019 OTCQX Best 50 were ranked based on their performance in 2018.
"It's an honor to be recognized by OTC Markets as the third best performing stock traded on the OTCQX Best Market in 2018," said Julius Kalcevich, CFO at iAnthus. "As investors pay closer attention to the cannabis industry, it becomes increasingly clear that iAnthus isn't just another cannabis stock, but a world-class operator working hard to deliver value to its shareholders. We look forward to an even stronger performance in 2019."
Crop Infrastructure Corp. announced today it will, initially, be making 100,000 premium Moon Rock Cones at one of its California subsidiaries as it expands its footprint in the state.
The raw material will be finished cannabis from CROP's Humboldt County farm which is trimmed, high grade flower and will be for distillate input for cartridges and pre-rolls cones that will then be dipped in kief (cannabis crystals) to make the infused cones. The infused cones will be Hempire and Evolution branded with custom filters bearing the name. Additional equipment to fulfill the order is expected to arrive shortly.
After some initial market research, the company has established the best-selling SKUS are cones and pens. The company has instructed its toll process partner to convert equivalent material to produce approximately 50 liters of oil to fill 75,000 half gram cartridges and 50,000 quarter gram disposable pens, as well as the company will roll and tube approximately 200,000 Hempire and evolution branded 1-gram infused cones.
CROP also announced it has made a cannabis retail application in Chula Vista, California, for its Emerald Height's brand and is working with its local partners to apply in additional municipalities.
Westleaf Inc. announced that it has exercised its option to acquire 100% of Canndara Canada Inc., a cannabis retail company with over fifty (50) prospective premium retail locations across Canada. On Dec. 20, 2018, Westleaf purchased 21.4% of the Class "A" common voting shares of Canndara and secured an option to acquire the remaining 78.6% of the Canndara Shares for an aggregate purchase price of $48.4 million. The Purchase Price is payable in common shares in the capital of Westleaf at a deemed value of $2.24 per Common Share. Closing is expected to occur on or about January 31, 2019.
Canndara's locations are at varying stages of development with seventeen (17) development permits already awarded in Western Canada. As a result of the transaction, Westleaf has increased its guidance from 20 to 30 cannabis retail locations to approximately 50 locations, that are expected to be operating by the end of 2020, subject to provincial and municipal licensing and regulations.
"Since the announcement of our original investment we continue to be impressed with the progress of the development of the Canndara retail portfolio and how well it complements the Westleaf Prairie Records retail locations. This acquisition will position Westleaf to become one of the largest premium cannabis retailers in Western Canada." said Scott Hurd, President and CEO of Westleaf. "Cannabis retail is the cornerstone of our vertically integrated strategy as the unique Prairie Records concept enables Westleaf to engage with consumers and build brand equity and loyalty for its stores and produced product brands."
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment